Onderzoeker
Armand Van Deun
- Trefwoorden:B230-bacteriologie, B680-volksgezondheid, B725-diagnostiek, B726-klinische-biologie
Affiliaties
- Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf31 dec 1998 → 29 nov 2018 - Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf31 dec 1998 → 16 apr 2015
Projecten
1 - 4 of 4
- Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without Creating MoreVanaf1 okt 2018 → Heden
- Trend and significance of INH resistance in DF BdeshVanaf1 jan 2018 → 31 dec 2018
- Trend of fluoroquinolone resistance among the MDR in DF BangladeshVanaf1 jan 2017 → 31 dec 2018
- Validity and feasability of use of a rapid and innovative test for detection of Multi Drug Resistant (MDR) TB cases in Kinshasa, DRCVanaf1 mrt 2009 → 6 jul 2018
Publicaties
31 - 40 van 142
- Short-course regimen for multidrug-resistant tuberculosis: a decade of evidence(2020)
Auteurs: Arnaud Trebucq, Tom Decroo, Armand Van Deun, Alberto Piubello, Chen-Yuan Chiang, Kobto G. Koura, Valerie Schwoebel
- World Health Organization 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forward(2020)
Auteurs: Armand Van Deun, Tom Decroo, Sabira Tahseen, Arnaud Trebucq, Valerie Schwoebel, Nimer Ortuno-Gutierrez, Bouke de Jong, Hans L. Rieder, Alberto Piubello, Chen-Yuan Chiang
- Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis(2020)
Auteurs: Syed Abidi, Jay Achar, Mourtala Mohamed Assao-Neino, Didi Bang, Andrea Benedetti, Sarah Brode, Jonathon R. Campbell, Esther C. Casas, Francesca Conradie, Gunta Dravniece, et al.
- Outcome definitions for multidrug-resistant tuberculosis treated with shorter treatment regimens(2019)
Auteurs: V. Schwoebel, C.Y. Chiang, A Trebucq, A Piubello, N. Ait-Khaled, K. G. Koura, Einar Heldal, Armand Van Deun, H L Rieder
Pagina's: 619-624 - Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance(2019)
Auteurs: Armand Van Deun, Emmanuel André, Justine Kaisergruber, Willy Ssengooba, Christel Desmaretz, Siemon Gabriëls, Michèle Driesen, Maren Diels, Sylvie Asnong, Kristina Fissette, et al.
- Multidrug-resistant tuberculosis(2019)
Auteurs: Chen-Yuan Chiang, Armand Van Deun, Arnaud Trebucq, Alberto Piubello, Valerie Schwoebel, Hans L. Rieder
Pagina's: 299-299 - In reply: a human rights-based approach to tuberculosis diagnosis(2019)
Auteurs: Armand Van Deun, Sabira Tahseen, Dissou Affolabi, Anwar Hossain, Moses L Joloba, Pawan K. Angra, John C. Ridderhof, Bouke de Jong, Hans L. Rieder
Pagina's: 959-960 - Gatifloxacin is superior to levofloxacin and moxifloxacin in shorter treatment regimens for multidrug-resistant TB(2019)
Auteurs: Armand Van Deun, Tom Decroo, C Kuaban, J Noeske, A Piubello, K.J.M. Aung, H L Rieder
Pagina's: 965-971 - Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries(2018)
Auteurs: A Trebucq, V. Schwoebel, Z. Kashongwe, A. Bakayoko, C Kuaban, J Noeske, S. Hassane, B. Souleymane, A Piubello, F. Ciza, et al.
Pagina's: 17-25 - Should gatifloxacin be included in the model list of essential medicines?(2018)
Auteurs: Chen-Yuan Chiang, Arnaud Trebucq, Alberto Piubello, Hans L. Rieder, Armand Van Deun